Anti-Osteoporotic Therapy After Fragility Fracture Lowers Rate of Subsequent Fracture: Analysis of a Large Population Sample

Conclusions:
Treatment with anti-osteoporotic therapy after a fragility fracture leads to a 40% decrease in the three-year risk of subsequent fracture, when adjusted for age and sex. Initiation of anti-osteoporotic therapy following a fragility fracture can prevent a subsequent fracture over the following three years in approximately one of every twenty-seven patients treated.

Level of Evidence:
Therapeutic Level III. See Instructions for Authors for a complete description of levels of evidence.

Source: The Journal of Bone and Joint Surgery - October 7, 2015 Category: Orthopaedics Authors: Bawa, H. S., Weick, J., Dirschl, D. R. Tags: Trauma Scientific Articles Source Type: research